What are the differences between Movicol (macrogol 3350 with electrolytes) and Osmolax (lactulose)?

Movicol vs Osmolax: Key Differences

Movicol and Osmolax are both osmotic laxatives but contain completely different active ingredients: Movicol contains macrogol (polyethylene glycol 3350) with electrolytes, while Osmolax contains macrogol 3350 without electrolytes—they are NOT the same as lactulose, which is a separate osmotic laxative altogether.

Active Ingredient Composition

• Movicol: Contains PEG 3350 (macrogol 3350) plus electrolytes (sodium, potassium, bicarbonate, and chloride) 1
• Osmolax: Contains PEG 3350 (macrogol 3350) without electrolytes 1
• Both products share the same base osmotic agent (PEG 3350) but differ in electrolyte content 1

Dosing Differences

• Movicol (PEG 3350 + electrolytes): Studied at 17.5 g twice daily in clinical trials 1
• Osmolax (PEG 3350 without electrolytes): Standard dose is 17 g once daily, available over-the-counter 1
• Both formulations demonstrate comparable efficacy in relieving constipation despite dosing differences 1

Clinical Efficacy

• Both formulations are equally effective for chronic constipation, with PEG 3350 increasing complete spontaneous bowel movements by approximately 2.9 per week compared to placebo 1
• Sustained efficacy is maintained over 6-month treatment periods for both formulations 1
• The AGA suggests using PEG laxatives (either formulation) as first-line pharmacologic therapy for constipation, though the evidence quality is low for IBS-C specifically 2

Safety Profile Comparison

• Common adverse effects are similar for both: bloating, flatulence, diarrhea, abdominal distension, loose stools, and nausea 1
• Diarrhea risk: Approximately 158 additional cases per 1,000 patients versus placebo, with incidence declining after the first week 1
• Electrolyte disturbances: Theoretically lower risk with Movicol (contains replacement electrolytes) versus Osmolax (no electrolytes), though serious electrolyte abnormalities are rare with either formulation 3
• Serious adverse events are rare with both, pooled relative risk 0.47 (95% CI 0.16–1.33) 1

Practical Considerations

• Taste preference: Patients generally prefer the taste of macrogol 4000 (similar to Osmolax) over macrogol 3350 with electrolytes (Movicol) 4
• Cost-effectiveness: Both PEG formulations are highly cost-effective at $10–$45 per month, far less expensive than prescription alternatives 1
• Over-the-counter availability: Osmolax (PEG without electrolytes) is more widely available OTC in many countries 1

Treatment Algorithm

• First-line choice: Either Movicol or Osmolax can be used as first-line osmotic laxative therapy; the choice depends primarily on availability, cost, and patient taste preference 1
• Electrolyte considerations: Use Movicol (with electrolytes) in patients at higher risk of electrolyte depletion (elderly, those on diuretics, or with renal impairment) 3
• Dose titration: Start with standard dosing and adjust upward based on response; higher doses increase diarrhea risk 1
• Duration: Both are safe for continuous use up to 6 months based on clinical evidence, despite FDA labeling for occasional use only 1

Common Pitfall to Avoid

• Do not confuse PEG products with lactulose—lactulose is a different osmotic laxative that is less effective than either Movicol or Osmolax, causes more flatulence and bloating, and is not preferred in current guidelines 5, 6, 7, 4